Alcon

Alcon and STAAR Surgical announced the postponement of STAAR’s Special Meeting of Stockholders regarding their proposed merger. Originally scheduled for October 23, 2025, it’s now set for November 6, 2025. The record date for voting eligibility remains September 12, 2025. The merger aims to strengthen Alcon’s refractive surgery market position through STAAR’s ICL technology. Analysts suggest regulatory reviews and due diligence contributed to the delay. The combined entity anticipates innovation in intraocular lens technology but faces integration challenges and market competition.

Alcon will showcase its latest advancements in cataract, refractive, and glaucoma technologies at the upcoming ESCRS in Copenhagen. Key highlights include the European launch of UNITY VCS, Clareon Vivity IOL, and Voyager DSLT. Alcon will present over 40 studies, focusing on Vivity IOL outcomes, the CENTURION system’s performance, and Wavelight plus data demonstrating superior refractive outcomes compared to SMILE for myopia correction. These innovations and data aim to strengthen Alcon’s position and expand its market share in Europe.